Reverse Pseudohyperkalemia: An Important Clinical Entity in Chronic Lymphocytic Leukemia

Reverse Pseudohyperkalemia: An Important Clinical Entity in Chronic Lymphocytic Leukemia

Hyperkalemia is a potentially lethal electrolyte derangement commonly seen in patients with hematologic neoplasms with or without renal failure. Pseudohyperkalemia and reverse pseudohyperkalemia also can be seen in this patient population and early recognition and diagnosis of these conditions are v...

Full description

Bibliographic Details
Main Authors: Sahar Mansoor, Noa G. Holtzman, Ashkan Emadi
Format: Article
Language:English
Published: Hindawi Limited 2015-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/2015/930379
id doaj-1461adc10bda4619938792a7fdf850f1
record_format Article
spelling doaj-1461adc10bda4619938792a7fdf850f12020-11-24T23:22:57ZengHindawi LimitedCase Reports in Hematology2090-65602090-65792015-01-01201510.1155/2015/930379930379Reverse Pseudohyperkalemia: An Important Clinical Entity in Chronic Lymphocytic LeukemiaSahar Mansoor0Noa G. Holtzman1Ashkan Emadi2University of Maryland School of Medicine, Marlene & Stewart Greenebaum Cancer Center, Baltimore, MD 21201, USAUniversity of Maryland School of Medicine, Marlene & Stewart Greenebaum Cancer Center, Baltimore, MD 21201, USAUniversity of Maryland School of Medicine, Marlene & Stewart Greenebaum Cancer Center, Baltimore, MD 21201, USAHyperkalemia is a potentially lethal electrolyte derangement commonly seen in patients with hematologic neoplasms with or without renal failure. Pseudohyperkalemia and reverse pseudohyperkalemia also can be seen in this patient population and early recognition and diagnosis of these conditions are vital. Here, we report a case of reverse pseudohyperkalemia in a patient with chronic lymphocytic leukemia (CLL) and provide recommendations regarding diagnostic and therapeutic strategies for management of such patients. Further, we discuss the pathogenesis of this condition and its potential role as a surrogate of favorable prognostic features in patients with CLL.http://dx.doi.org/10.1155/2015/930379
collection DOAJ
language English
format Article
sources DOAJ
author Sahar Mansoor
Noa G. Holtzman
Ashkan Emadi
spellingShingle Sahar Mansoor
Noa G. Holtzman
Ashkan Emadi
Reverse Pseudohyperkalemia: An Important Clinical Entity in Chronic Lymphocytic Leukemia
Case Reports in Hematology
author_facet Sahar Mansoor
Noa G. Holtzman
Ashkan Emadi
author_sort Sahar Mansoor
title Reverse Pseudohyperkalemia: An Important Clinical Entity in Chronic Lymphocytic Leukemia
title_short Reverse Pseudohyperkalemia: An Important Clinical Entity in Chronic Lymphocytic Leukemia
title_full Reverse Pseudohyperkalemia: An Important Clinical Entity in Chronic Lymphocytic Leukemia
title_fullStr Reverse Pseudohyperkalemia: An Important Clinical Entity in Chronic Lymphocytic Leukemia
title_full_unstemmed Reverse Pseudohyperkalemia: An Important Clinical Entity in Chronic Lymphocytic Leukemia
title_sort reverse pseudohyperkalemia: an important clinical entity in chronic lymphocytic leukemia
publisher Hindawi Limited
series Case Reports in Hematology
issn 2090-6560
2090-6579
publishDate 2015-01-01
description Hyperkalemia is a potentially lethal electrolyte derangement commonly seen in patients with hematologic neoplasms with or without renal failure. Pseudohyperkalemia and reverse pseudohyperkalemia also can be seen in this patient population and early recognition and diagnosis of these conditions are vital. Here, we report a case of reverse pseudohyperkalemia in a patient with chronic lymphocytic leukemia (CLL) and provide recommendations regarding diagnostic and therapeutic strategies for management of such patients. Further, we discuss the pathogenesis of this condition and its potential role as a surrogate of favorable prognostic features in patients with CLL.
url http://dx.doi.org/10.1155/2015/930379
work_keys_str_mv AT saharmansoor reversepseudohyperkalemiaanimportantclinicalentityinchroniclymphocyticleukemia
AT noagholtzman reversepseudohyperkalemiaanimportantclinicalentityinchroniclymphocyticleukemia
AT ashkanemadi reversepseudohyperkalemiaanimportantclinicalentityinchroniclymphocyticleukemia
_version_ 1725566074832814080

Similar Items